Transfer of health technology supervision duties from Valvira to Fimea proceeding as planned
The transfer of the duties concerning health technology supervision from Valvira to Fimea, also including the transfer and reforms of related registers, are proceeding as planned.
The duties that are to be transferred are the supervision of health care devices and equipment (medicinal devices and in vitro diagnostic devices), duties related to the guidance, supervision and registration of biobanks, the licensing and supervision duties specified in the Act on the Medical Use of Human Organs and Tissues that currently belong to Valvira, duties related to embryo research, and the supervision duties related to the Gene Technology Act.
The duties and affiliated personnel will be relocated to Fimea by 31 December 2019. The aim is to also have the reform project of the register for health care devices and equipment completed by 31 December 2019, after which potential reform projects will be initiated for the biobank and gene technology registers as well.
- Fimea: Johanna Nystedt, Director of Supervision and Licences, tel. +358 295 223 210
- Valvira: Jussi Holmalahti, Director of the Department for Health, Legal Rights and Technologies, tel. +358 295 209 500